Interviews
Dr. Olderman presents value of Bonded Antimicrobial at Textiles Conf
08 Feb '08
2 min read
Quick-Med Technologies' Vice President of Research & Development and Commercialization, Gerald M. Olderman, Ph.D., presented “Unique and New: A Bonded Antimicrobial Concept,” at the recent Summit Session on Antimicrobials in Plastic and Textile Applications Conference.
Dr. Olderman's presentation showcased the multiple advantages of Quick-Med Technologies' patented NIMBUS antimicrobial technology and emphasized the uniqueness of a bonded antimicrobial.
NIMBUS is the only commercially available antimicrobial technology in which a large, multi-active polymer is permanently bonded to any of a number of base materials. NIMBUS is an acronym for Novel Intrinsic Micro-Bonded Utility Substrate.
Ordinary commercial antimicrobials work by “releasing” or “leaching” their active agents. Sooner or later, this results in depletion of the agent which has several significant drawbacks including loss of antimicrobial protection and an increase in likelihood of spawning antimicrobial resistance (i.e. so called “super bugs”) as levels drop below the levels needed for effective microbial kill rates.
Because NIMBUS is permanently bonded and does not deplete, it will not fall below the level needed to achieve inactivation (kill microbes) and thus avoids the potential for bacteria to develop a resistance.
Studies conducted by the company, as well as by independent laboratories, demonstrate that NIMBUS is highly effective, including against Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE), two of the most significant antibiotic-resistant organisms responsible for hospital-acquired and community-acquired infections.
Dr. Olderman's presentation showcased the multiple advantages of Quick-Med Technologies' patented NIMBUS antimicrobial technology and emphasized the uniqueness of a bonded antimicrobial.
NIMBUS is the only commercially available antimicrobial technology in which a large, multi-active polymer is permanently bonded to any of a number of base materials. NIMBUS is an acronym for Novel Intrinsic Micro-Bonded Utility Substrate.
Ordinary commercial antimicrobials work by “releasing” or “leaching” their active agents. Sooner or later, this results in depletion of the agent which has several significant drawbacks including loss of antimicrobial protection and an increase in likelihood of spawning antimicrobial resistance (i.e. so called “super bugs”) as levels drop below the levels needed for effective microbial kill rates.
Because NIMBUS is permanently bonded and does not deplete, it will not fall below the level needed to achieve inactivation (kill microbes) and thus avoids the potential for bacteria to develop a resistance.
Studies conducted by the company, as well as by independent laboratories, demonstrate that NIMBUS is highly effective, including against Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE), two of the most significant antibiotic-resistant organisms responsible for hospital-acquired and community-acquired infections.
Popular News
Leave your Comments
Editor’s Pick
Folker Stachetzki
Brother Internationale Industriemaschinen GmbH
Pratik Gadia
The Yarn Bazaar - Filosha Infotech Private Limited
Esteemed Clients
-Ltd..jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Thermore (Far East) Ltd.")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Telangana State Industrial Infrastructure Corporation Limited (TSllC Ltd)")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Taiwan Textile Federation (TTF)")
